My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 202

    1.

    Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver.

    Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B.

    Diabetes. 2005 May;54(5):1331-9.PMID: 15855317 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression.

    Viana AY, Sakoda H, Anai M, Fujishiro M, Ono H, Kushiyama A, Fukushima Y, Sato Y, Oshida Y, Uchijima Y, Kurihara H, Asano T.

    Diabetes Res Clin Pract. 2006 Aug;73(2):135-42. Epub 2006 Feb 28.PMID: 16503364 [PubMed - indexed for MEDLINE]Related articles

    3.

    Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice.

    Yang J, Maika S, Craddock L, King JA, Liu ZM.

    Biochem Biophys Res Commun. 2008 May 30;370(2):248-53. Epub 2008 Mar 31.PMID: 18381066 [PubMed - indexed for MEDLINE]Related articles

    4.

    Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.

    Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, Lee CH, Choi HS.

    Diabetes. 2008 Feb;57(2):306-14. Epub 2007 Oct 1.PMID: 17909097 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.

    Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Enjoji M, Takayanagi R, Nakamuta M.

    Int J Mol Med. 2008 Apr;21(4):507-11.PMID: 18360697 [PubMed - indexed for MEDLINE]Related articles

    6.

    Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.

    Andreelli F, Foretz M, Knauf C, Cani PD, Perrin C, Iglesias MA, Pillot B, Bado A, Tronche F, Mithieux G, Vaulont S, Burcelin R, Viollet B.

    Endocrinology. 2006 May;147(5):2432-41. Epub 2006 Feb 2.PMID: 16455782 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The role of AMP-activated protein kinase in the action of ethanol in the liver.

    You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW.

    Gastroenterology. 2004 Dec;127(6):1798-808.PMID: 15578517 [PubMed - indexed for MEDLINE]Related articles

    8.

    Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways.

    Park KG, Min AK, Koh EH, Kim HS, Kim MO, Park HS, Kim YD, Yoon TS, Jang BK, Hwang JS, Kim JB, Choi HS, Park JY, Lee IK, Lee KU.

    Hepatology. 2008 Nov;48(5):1477-86.PMID: 18972440 [PubMed - indexed for MEDLINE]Related articles

    9.

    Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.

    Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F.

    Diabetes Metab. 2007 Dec;33(6):395-402. Epub 2007 Nov 7. Review.PMID: 17997341 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes.

    Du J, Chen Q, Takemori H, Xu H.

    Obesity (Silver Spring). 2008 Mar;16(3):531-8. Epub 2008 Jan 17.PMID: 18239551 [PubMed - indexed for MEDLINE]Related articles

    11.

    Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase.

    Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K.

    J Biol Chem. 2002 Feb 8;277(6):3829-35. Epub 2001 Nov 27.PMID: 11724780 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase.

    Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferré P, Foufelle F, Carling D.

    Mol Cell Biol. 2000 Sep;20(18):6704-11.PMID: 10958668 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit.

    Villena JA, Viollet B, Andreelli F, Kahn A, Vaulont S, Sul HS.

    Diabetes. 2004 Sep;53(9):2242-9.PMID: 15331533 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement.

    Ono H, Shimano H, Katagiri H, Yahagi N, Sakoda H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Viana AY, Fukushima Y, Abe M, Shojima N, Kikuchi M, Yamada N, Oka Y, Asano T.

    Diabetes. 2003 Dec;52(12):2905-13.PMID: 14633850 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target.

    Muoio DM, Seefeld K, Witters LA, Coleman RA.

    Biochem J. 1999 Mar 15;338 ( Pt 3):783-91.PMID: 10051453 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice.

    Sakakibara S, Yamauchi T, Oshima Y, Tsukamoto Y, Kadowaki T.

    Biochem Biophys Res Commun. 2006 Jun 2;344(2):597-604. Epub 2006 Apr 5.PMID: 16630552 [PubMed - indexed for MEDLINE]Related articles

    17.

    Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.

    Yoon YS, Seo WY, Lee MW, Kim ST, Koo SH.

    J Biol Chem. 2009 Apr 17;284(16):10446-52. Epub 2009 Feb 25.PMID: 19244231 [PubMed - indexed for MEDLINE]Related articles

    18.

    Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver.

    Liang CP, Tall AR.

    J Biol Chem. 2001 Dec 28;276(52):49066-76. Epub 2001 Sep 10.PMID: 11551957 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

    Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.

    Diabetes. 2006 Aug;55(8):2159-70.PMID: 16873678 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    AMP-activated protein kinase and carbohydrate response element binding protein: a study of two potential regulatory factors in the hepatic lipogenic program of broiler chickens.

    Proszkowiec-Weglarz M, Richards MP, Humphrey BD, Rosebrough RW, McMurtry JP.

    Comp Biochem Physiol B Biochem Mol Biol. 2009 Sep;154(1):68-79. Epub 2009 May 8.PMID: 19427916 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity